Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LUCID DIAGNOSTICS LABS LLC

NPI: 1790482347 · LEXINGTON, KY 40504 · Clinical Medical Laboratory · NPI assigned 02/14/2023

$19K
Total Medicaid Paid
708
Total Claims
390
Beneficiaries
3
Codes Billed
2023-08
First Month
2023-12
Last Month

Provider Details

Authorized OfficialNARAHARI, MADHUKAR (OWNER)
NPI Enumeration Date02/14/2023

Related Entities

Other providers sharing the same authorized official: NARAHARI, MADHUKAR

ProviderCityStateTotal Paid
AUTUMN TREATMENT CENTER LLC CIRCLEVILLE OH $1.90M
AUTUMN TREATMENT CENTER LLC CIRCLEVILLE OH $913K
JYOTHI PURAM, M.D., INC SPRINGFIELD OH $50K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2023 708 $19K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 440 196 $14K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 250 178 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 18 16 $539.34